Fonadelpar
Modify Date: 2025-08-25 12:14:54
Fonadelpar structure
|
Common Name | Fonadelpar | ||
|---|---|---|---|---|
| CAS Number | 515138-06-4 | Molecular Weight | 504.521 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 607.6±65.0 °C at 760 mmHg | |
| Molecular Formula | C25H23F3N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 321.3±34.3 °C | |
Use of FonadelparFonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy. |
| Name | fonadelpar |
|---|---|
| Synonym | More Synonyms |
| Description | Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy. |
|---|---|
| Related Catalog | |
| Target |
PPARδ |
| In Vitro | Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 607.6±65.0 °C at 760 mmHg |
| Molecular Formula | C25H23F3N2O4S |
| Molecular Weight | 504.521 |
| Flash Point | 321.3±34.3 °C |
| Exact Mass | 504.133057 |
| LogP | 7.02 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.587 |
| fonadelpar |
| FK5ZAD810Z |
| {[3-(2-{4-Isopropyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}ethyl)-5-methyl-1,2-benzoxazol-6-yl]oxy}acetic acid |
| Acetic acid, 2-[[5-methyl-3-[2-[4-(1-methylethyl)-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]- |